Antiphospholipid syndrome and cognition

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 2, 2007, Pages 188-191

  Liberato, Bernardo ^a   Levy, Roger A ^b,c  

^a Neurology   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Diagnósticos da America S A   (Brazil)

Author keywords

Antiphospholipid syndrome; Cognition; Systemic lupus erythematosus

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; BRAIN FUNCTION; COGNITION; CONFUSION; DEMENTIA; HUMAN; INFLAMMATION; NEUROIMAGING; PATHOGENICITY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CEREBRAL INFARCTION; COGNITION; FEMALE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PREGNANCY;

EID: 35348857482     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0007-x     Document Type: Review

References (16)

1. Sanna G, Bertolaccini ML, Cuadrado MJ et al (2003) Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 42:200-213
2. Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD (1997) Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 100(3):613-619
3. Hess DC, Taormina M, Thompson J et al (1993) Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 20(4):610-617
4. Shoenfeld Y, Nahum A, Korczyn AD et al (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436-442
5. Caronti B, Pittoni V, Palladini G, Valesini G (1998) Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156(2):211-219
6. Caronti B, Calderaro C, Alessandri C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11(5):425-429
7. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD (1999) Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8(2):127-133
8. Cimaz R, Meroni PL, Shoenfeld Y (2006) Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughe's syndrome). Lupus 15(4):191-197
9. Chinn RJ, Wilkinson ID, Hall-Craggs MA et al (1997) Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40 (1):36-46
10. Kozora E, West SG, Kotzin BL et al (1998) Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 41(1):41-47
11. Hilker R, Thiel A, Geisen C, Rudolf J (2000) Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. Lupus 9(4):311-316
12. Sibbitt WL Jr, Haseler LJ, Griffey RR et al Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. Am J Neuroradiol YEAR 18:1271-1277
13. Sabet A, Sibbitt WL Jr, Stidley CA et al (1998) Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 29: 2254-2260
14. Kozora E, Arciniegas DB, Filley CM et al (2005) Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 18(3):159-162
15. Appenzeller S, Li LM, Costallat L, Cendes F (2005) Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. Brain 128(12):2933-2940
16. Castellino G, Govoni M, Padovan M et al (2005) Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 64:1022-1027